Can Augmentin (amoxicillin‑clavulanate) be co‑administered with allopurinol in an adult without known penicillin, sulfonamide, or allopurinol allergy, and are any dose adjustments or increased risk of skin reactions required?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin and Allopurinol Interaction

Augmentin (amoxicillin-clavulanate) can be co-administered with allopurinol, but the concurrent use increases the incidence of skin rashes compared to amoxicillin alone. 1

Key Interaction: Increased Rash Risk

The FDA drug label explicitly states that concurrent administration of allopurinol and amoxicillin increases the incidence of rashes in patients receiving both drugs compared to patients receiving amoxicillin alone. 1 It remains unclear whether this potentiation of rashes is due to allopurinol itself or the underlying hyperuricemia present in these patients. 1

Clinical Management Approach

No dose adjustments are required for either medication when used together. 1 The interaction is primarily dermatologic rather than pharmacokinetic:

  • Monitor closely for skin reactions during the first few days of concurrent therapy 1
  • Counsel patients to report any rash, itching, or skin changes immediately 1
  • Consider the clinical necessity of using both agents simultaneously, particularly if alternative antibiotics are available 1

Important Distinction from Azathioprine

The allopurinol interaction with Augmentin differs fundamentally from its interaction with thiopurine drugs (azathioprine, 6-mercaptopurine):

  • With thiopurines: Allopurinol requires a 65-75% dose reduction of the chemotherapeutic agent due to severe myelotoxicity risk 2, 3, 4
  • With Augmentin: No dose adjustment is needed; only increased rash surveillance is required 1

Risk Stratification

Patients at higher baseline risk for allopurinol hypersensitivity reactions (Han-Chinese, Korean, Thai populations with HLA-B*58:01) may warrant extra caution when adding Augmentin, though this specific combination has not been studied in these populations. 2

Common Pitfall to Avoid

Do not confuse this interaction with the allopurinol-azathioprine interaction. The latter requires dramatic dose reduction and close hematologic monitoring 5, while the Augmentin-allopurinol combination simply requires dermatologic vigilance without dose modification. 1

References

Guideline

Allopurinol Therapy Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Allopurinol Therapy Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Allopurinol Dosing for Prevention of Hyperuricemia in Patients Undergoing Chemotherapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.